A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care. By Reed Abelson and Teddy Rosenbluth Like millions ...

The most frequent human enzyme deficiency involves glucose-6-phosphate dehydrogenase (G6PD), the committed enzyme of the oxidative pentose phosphate pathway. Mild G6PD deficiency protects against ...

First of all, 30 mg. of primaquine was administered daily to 2 G6PD-deficient Sardinians. When the hematocrit dropped to 24 per cent and 22 per cent respectively, the drug was withdrawn. Ten and ...

Disparities in outcomes of metastatic prostate cancer hospitalizations: 2008-2021. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text ...

On 18 December 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency which can help to safely deliver WHO-recommended ...

A transjugular intrahepatic portosystemic shunt (TIPS for short) is a procedure meant to help blood flow more easily through your liver. It’s usually done to treat complications caused by liver damage ...

Doctors perform a number of different outpatient heart procedures, including angioplasty, stenting, pacemaker implantation, and others. If you have a heart condition, your doctor might recommend an ...

Call it dental h-AI-genics. A Boston-based tech company, backed by Mark Zuckerberg’s dentist father, has successfully managed the world’s first all-robotic dental procedure. Perceptive, a business ...

The authors probed Medicare Part B data to explore outpatient clinical procedures performed by physician associates and nurse practitioners and report the trends from 2014 through 2021. Objective: We ...

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Four years ago, researchers warned the Centers for Medicare ...

In a recent study published in Nutrients, researchers investigated the risk of Attention Deficit/Hyperactivity Disorder (ADHD) among glucose 6-phosphate dehydrogenase (G6PD)-deficient individuals.